亚太地区膀胱过度活动症治疗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按药物治疗（抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱内滴注）和疾病类型（特发性膀胱过度活动症和神经源性膀胱）
No. of Pages: 160 | Report Code: BMIRE00027905 | Category: Life Sciences
No. of Pages: 160 | Report Code: BMIRE00027905 | Category: Life Sciences
强大的管道药物和新疗法的相继推出，支持亚太地区膀胱过度活动症治疗
2020年12月，一种新药Gemtesa 的申请已获批准，这是一种 β3 激动剂，也是一种治疗成人膀胱过度活动症的新型疗法。 Urovant Sciences 提供的 Gemtesa (vibegron) 有助于放松膀胱逼尿肌，使膀胱能够容纳更多尿液；该肌肉的放松可减轻膀胱过度活动症的症状。它是一种每日一次的药丸，也是第一种不需要剂量滴定的膀胱过度活动症药物。许多大学和学术机构正在开展针对治疗 OAB 的新型分子的强有力的研究和开发活动。例如，韩国首尔的延世大学医学院和 Severance 医院正在评估 DA8010，一种新型毒蕈碱 M3 受体拮抗剂。 2021年9月，该大学发布消息称，在2期试验中，M3拮抗剂DA8010被证明对于膀胱过度活动症治疗的有效性和安全性。膀胱过度活动症治疗药物的强劲管道以及新药和疗法的陆续推出预计将在未来几年推动亚太地区膀胱过度活动症治疗市场的增长。
亚太地区膀胱过度活动症治疗市场概览
< /p>
亚太地区膀胱过度活动症治疗市场分为中国、日本、印度、韩国、澳大利亚、韩国和亚太地区其他地区。市场增长归因于老年人口的增加、尿失禁病例的增加以及产品推出数量的增加。膀胱过度活动症是由于腹部外伤、尿路感染、尿失禁、神经损伤等引起的。根据国家生物技术中心（NCBI）的数据，2019年，中国40岁以上的人中，每5人就有1人患有膀胱过度活动综合症。 《中华医学杂志》称，2019年18岁以上人群膀胱过度活动症发病率为5.9%。世界卫生组织预计，中国60岁人群这一比例预计将从2021年的10%增长到2041年的28%。此外，根据《世界人口老龄化2019》，香港2019年60岁或以上的人口占总人口的17.5%。随着老年人口不断增加，患有膀胱过度活动症和尿路感染的患者人数也不断增加。预计未来几年将会增加。所有这些因素都促进了亚太地区膀胱过度活动症治疗市场的增长。
亚太地区膀胱过度活动症治疗市场细分
亚太地区膀胱过度活动症治疗市场根据药物治疗、疾病类型和国家/地区进行细分。
根据药物治疗，亚太地区膀胱过度活动症治疗市场分为抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱灌注。 2022 年，米拉贝隆细分市场在亚太地区膀胱过度活动症治疗市场中占据最大份额。
根据疾病类型，亚太地区膀胱过度活动症治疗市场分为特发性膀胱过度活动症和神经源性膀胱。 2022 年，特发性膀胱过度活动症细分市场将占据更大的市场份额。
按国家/地区划分，亚太地区膀胱过度活动症治疗市场细分为中国、日本、印度、韩国、澳大利亚、韩国和亚太其他地区。 2022 年，中国将主导市场。
艾伯维公司 (AbbVie Inc;) Alembic 制药有限公司；安斯泰来制药公司；远藤制药公司；久光制药有限公司；美敦力公司；辉瑞公司；和 Teva Pharmaceutical Industries Ltd 是亚太地区膀胱过度活动症治疗市场的领先公司。
Strategic insights for Asia Pacific Overactive Bladder Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 871.48 Million |
| Market Size by 2028 | US$ 1,082.25 Million |
| Global CAGR (2022 - 2028) | 3.7% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Overactive Bladder Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Overactive Bladder Treatment Market is valued at US$ 871.48 Million in 2022, it is projected to reach US$ 1,082.25 Million by 2028.
As per our report Asia Pacific Overactive Bladder Treatment Market, the market size is valued at US$ 871.48 Million in 2022, projecting it to reach US$ 1,082.25 Million by 2028. This translates to a CAGR of approximately 3.7% during the forecast period.
The Asia Pacific Overactive Bladder Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Overactive Bladder Treatment Market report:
The Asia Pacific Overactive Bladder Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Overactive Bladder Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Overactive Bladder Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Overactive Bladder Treatment Market
